Can hyperpolarized helium MRI add to radiation planning and follow-up in lung cancer?

Journal of Applied Clinical Medical Physics

Volumn 12, Issue 2, 2011, Pages 169-183

  Allen, Aaron M ^a   Albert, Mitchell ^a,b   Caglar, Hale B ^a   Zygmanski, Piotr ^a   Soto, Ricardo ^a   Killoran, Joseph ^a   Sun, Yangping ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Functional imaging; Helium MRI; IMRT; Lung cancer

Indexed keywords

EID: 79960513858     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v12i2.3357     Document Type: Article

References (21)

1. Gandara DR, Chansky K, Albain KS, et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504. J Clin Oncol. 2003;21(10):2004-10.
2. Albain KS, Swann RS, Rusch VR, et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs. CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309) [abstract]. 2005 ASCO Annual Meeting Proceedings. J Clin Oncol. 2006;23(16S):7014.
3. Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63(2):324-33.
4. Rengan R, Rosenzweig KE, Venkatraman E, et al. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;60(3):741-47.
5. Bradley JD, Paulus R, Graham MV, et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group -RTOG 9705. J Clin Oncol. 2005;23(15):3480-87.
6. Socinski MA, Blackstock AW, Bogart JA, et al. Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. J Clin Oncol. 2008;26(15):2457-63.
7. Christian JA, Partridge M, Nioutsikou E, et al. The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer. Radiother Oncol. 2005;77(3):271-77.
8. Lavrenkov K, Christian JA, Partridge M, et al. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Radiother Oncol. 2007;83(2):156-62.
9. de Lange EE, Altes TA, Patrie JT, et al. The variability of regional airflow obstruction within the lungs of patients with asthma: assessment with hyperpolarized helium-3 magnetic resonance imaging. J Allergy Clin Immunol. 2007;119(5):1072-78.
10. Ley S, Zaporozhan J, Morbach A, et al. Functional evaluation of emphysema using diffusion-weighted 3Helium-magnetic resonance imaging, high-resolution computed tomography, and lung function tests. Invest Radiol. 2004;39(7):427-34.
11. van Beek EJ, Wild JM, Kauczor HU, Schreiber W, Mugler JP, 3rd, de Lange EE. Functional MRI of the lung using hyperpolarized 3-helium gas. J Magn Reson Imaging. 2004;20(4):540-54.
12. Swift AJ, Wild JM, Fichele S, et al. Emphysematous changes and normal variation in smokers and COPD patients using diffusion 3He MRI. Eur J Radiol. 2005;54(3):352-58.
13. Ireland RH, Bragg CM, McJury M, et al. Feasibility of image registration and intensity-modulated radiotherapy planning with hyperpolarized helium-3 magnetic resonance imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;68(1):273-81.
14. Ward ER, Hedlund LW, Kurylo WC, et al. Proton and hyperpolarized helium magnetic resonance imaging of radiation-induced lung injury in rats. Int J Radiat Oncol Biol Phys. 2004;58(5):1562-69.
15. Cai J, Mata JF, Orton MD, et al. A rabbit irradiation platform for outcome assessment of lung stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2009;73(5):1588-95.
16. Marks LB, Spencer DP, Bentel GC, et al. The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. Int J Radiat Oncol Biol Phys. 1993;26(4):659-68.
17. Marks LB, Spencer DP, Sherouse GW, et al. The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose-volume histogram. Int J Radiat Oncol Biol Phys. 1995;33(1):65-75.
18. Shioyama Y, Jang SY, Liu HH, et al. Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;68(5):1349-58.
19. McGuire SM, Zhou S, Marks LB, Dewhirst M, Yin FF, Das SK. A methodology for using SPECT to reduce intensity-modulated radiation therapy (IMRT) dose to functioning lung. Int J Radiat Oncol Biol Phys. 2006;66(5):1543-52.
20. Kauczor HU, Chen XJ, van Beek EJ, Schreiber WG. Pulmonary ventilation imaged by magnetic resonance: at the doorstep of clinical application. Eur Respir J. 2001;17(5):1008-23.
21. Petersson J, Sánchez-Crespo A, Larsson SA, Mure M. Physiological imaging of the lung: single-photon-emission computed tomography (SPECT). J Appl Physiol. 2007;102(1):468-76.